Articles and Blogs

This Week (September 15, 2023): Drug Enforcement Administration (“DEA”) officials have been holding pre-regulatory listening sessions with stakeholders to discuss a new special provider registration requirement for practitioners who are prescribing controlled substances through telehealth without first establishing a provider-patient relationship. Why it Matters: The special registration is mandated by the Ryan Haight Act,... READ MORE

In a Report and Order released March 30, 2021, the Federal Communications Commission (“FCC”) announced its plan to move forward with the second round of funding (“Round 2”) of its COVID-19 Telehealth Program (“Program”). As noted in our prior article, this announcement comes after Congress appropriated additional funding and directed the FCC to seek... READ MORE

While the COVID-19 public health emergency (“PHE”) has driven significant change throughout health care, some of the more expansive changes relate specifically to the provision of care through telehealth technology (“Virtual Care”). Given the nature and extent of the PHE flexibilities, use of telehealth has skyrocketed. Medicare beneficiaries used telehealth for 43.5% of their... READ MORE